Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.3061
+0.0062 (2.07%)
At close: Jul 31, 2026, 4:00 PM EDT
0.3039
-0.0022 (-0.72%)
After-hours: Jul 31, 2026, 8:00 PM EDT
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $6.55 million as of July 31, 2026. Its market cap has decreased by -58.62% in one year.
Market Cap
6.55M
Enterprise Value
2.88M
1-Year Change
-58.62%
Ranking
Category
Stock Price
$0.31
ChartMarket Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $6.55M, a decrease of -80.37%. That is a compound annual growth rate of -58.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 6.55M | -55.67% |
| Dec 31, 2025 | 14.78M | -24.29% |
| Dec 31, 2024 | 19.53M | -41.52% |
| Sep 16, 2024 | 33.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Can-Fite BioPharma | 7.21M |
| Adial Pharmaceuticals | 7.16M |
| Traws Pharma | 6.82M |
| Imunon | 6.68M |
| XTL Biopharmaceuticals | 6.41M |
| Pulmatrix | 6.35M |
| Alzamend Neuro | 6.28M |
| Addex Therapeutics | 6.19M |